Trending...
- Healthi Life, Bangkok's Urban Longevity House, Honoured at Asia-Pacific Awards 2025
- IDI Consulting Supports Crohn's & Colitis Foundation as Silver Sponsor for Pittsburgh Take Steps Walk
- Christmas Miracle Chronicles - New movie coming up this holiday season !
MEADOWBROOK, Pa., Sept. 22, 2023 ~ Phillip A. Villanueva, MD, ABNS, has been acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery. He is prominently featured in The Inner Circle.
Dr. Villanueva earned a Bachelor of Science degree with a double major in Biology and Chemistry and a minor in Theology and Philosophy from Biscayne College (St. Thomas University). He then attended the University of Miami Miller School of Medicine where he received a Medical Degree and completed his general surgery internship and neurosurgery residency at the University of Miami, Jackson Memorial Medical Center. Board-certified in Neurological Surgery and in Neuro-Critical Care, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care; treats aneurysms and all secondary issues regarding these conditions; and also manages the Neuroscience ICU consulting with neurologists.
More on The PennZone
Dr. Villanueva has served as the Director of Neuro Trauma and Critical Care at Temple University Hospital in Philadelphia, PA for over 8 years, as well as being a Professor of Clinical Neurosurgery at the Lewis Katz School of Medicine at Temple University. He is also a Fellow of the American Association of Neurological Surgeons; is a member of the American Association of Neurological Surgeons; and serves on the subcommittee for neuro-critical care. Additionally, he has created public service announcements to increase community awareness about brain trauma outside his neurology practice.
For his excellence in service, Dr. Villanueva has been awarded several times throughout his career including the Best Doctors in America Award in Neurological Surgery (2019-2020). He would like to dedicate this honor to his mentors Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.
Dr. Villanueva earned a Bachelor of Science degree with a double major in Biology and Chemistry and a minor in Theology and Philosophy from Biscayne College (St. Thomas University). He then attended the University of Miami Miller School of Medicine where he received a Medical Degree and completed his general surgery internship and neurosurgery residency at the University of Miami, Jackson Memorial Medical Center. Board-certified in Neurological Surgery and in Neuro-Critical Care, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care; treats aneurysms and all secondary issues regarding these conditions; and also manages the Neuroscience ICU consulting with neurologists.
More on The PennZone
- United Way and Community Partners Launch Relief Fund to Support Victims of the Six-Alarm Fire in Allentown
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Boston Industrial Solutions Introduces High-Performance Primer for Bonding Liquid Silicone to Epoxy
- Together We Thrive: Kingdom Life Health & Career Fair Unites Faith, Wellness and Opportunity
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
Dr. Villanueva has served as the Director of Neuro Trauma and Critical Care at Temple University Hospital in Philadelphia, PA for over 8 years, as well as being a Professor of Clinical Neurosurgery at the Lewis Katz School of Medicine at Temple University. He is also a Fellow of the American Association of Neurological Surgeons; is a member of the American Association of Neurological Surgeons; and serves on the subcommittee for neuro-critical care. Additionally, he has created public service announcements to increase community awareness about brain trauma outside his neurology practice.
For his excellence in service, Dr. Villanueva has been awarded several times throughout his career including the Best Doctors in America Award in Neurological Surgery (2019-2020). He would like to dedicate this honor to his mentors Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.
0 Comments
Latest on The PennZone
- Rare 1933 Harold Weston painting will be auctioned to benefit the Keene Valley Library
- $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
- HomeCentris Home Health Achieves 5-Star CMS Rating
- Adsoptia Launches AI-Powered Optimization Platform for a New Era of Autonomous Marketing Decisions
- Heritage at Manalapan Announces New Incentive: Included Finished Basement on Select Homesites
- Leicester UK Manufacturer Tabletop Tyrant Secures Flawless 100% Customer Satisfaction Rating Across 5,800+ Orders
- The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth
- Cango Mobility x Hikvision Announce Strategic Partnership
- Institute of Emerging Minds Publishes Framework for Glymphatic Clearance and Cognitive Optimization
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
- George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
- Mister Omaha Tries The Turf At Lone Star Park
- Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
- The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence
- Ghanaian Afrobeat Artist Praise Kusi Announces Upcoming EP "After 21:00" Releasing July 3, 2026
- Translational Scientist Roohid Parast Comments on FDA Approval of Icotrokinra for Psoriasis